Antiviral peptide and use therefor
AssigneesToagosei Co., Ltd., National University Corporation Hokkaido University
InventorsTetsuhiko YOSHIDA, Ayato TAKADA, Nahoko BAILEYKOBAYASHI
Life of this patent
Estimating the term…
Abstract
An antiviral peptide provided by the present invention includes: (1) the signal sequence of a glycoprotein encoded for by the G gene of the vesicular stomatitis virus (VSV), or the signal sequence of hemagglutinin encoded for by the HA gene of the influenza A or influenza B virus, or a modified amino acid sequence formed by conservative substitution of 1, 2 or 3 amino acid residues in any of these signal sequences; and (2) an amino acid sequence that functions as a cell penetrating peptide (CPP).
Claims8
A synthetic peptide that suppresses growth of at least one kind of virus, the synthetic peptide comprising amino acid sequences shown in (1) and (2) below:
- (1) a signal sequence of a glycoprotein encoded for by the G gene of the vesicular stomatitis virus (VSV), or a signal sequence of hemagglutinin encoded for by the HA gene of the influenza A or influenza B virus, or a modified amino acid sequence formed by conservative substitution of 1, 2 or 3 amino acid residues in any of these signal sequences;
- and
- (2) an amino acid sequence that functions as a cell penetrating peptide (CPP).
Dependencies are inferred from the claim text.